These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1533038

  • 1. [Nodular efflorescence and cutaneous vasculitis in rheumatoid arthritis treated with methotrexate].
    Lassoued S, Billey T, Pages M, Dromer C, Fournie B, Fournie A.
    Presse Med; 1992 Mar 07; 21(9):437. PubMed ID: 1533038
    [No Abstract] [Full Text] [Related]

  • 2. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T, Durez P, Margaux J, Van Geertruyden J, Goldschmidt D, Parent D.
    Clin Rheumatol; 1997 Nov 07; 16(6):623-5. PubMed ID: 9456017
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate related cutaneous vasculitis.
    Torner O, Ruber C, Olive A, Tena X.
    Clin Rheumatol; 1997 Jan 07; 16(1):108-9. PubMed ID: 9132315
    [No Abstract] [Full Text] [Related]

  • 4. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S, Giryes H, Avinoach I, Livni E, Sukenik S.
    J Eur Acad Dermatol Venereol; 1998 Jan 07; 10(1):81-5. PubMed ID: 9552765
    [Abstract] [Full Text] [Related]

  • 5. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A, Kannangara S, Barnsley L.
    Intern Med J; 2005 Oct 07; 35(10):638-40. PubMed ID: 16207269
    [No Abstract] [Full Text] [Related]

  • 6. Leukocytoclastic vasculitis associated with methotrexate therapy.
    Düzova A, Soysal A, Ozen S, Akyüz C, Gököz A, Yetgin S.
    Turk J Pediatr; 2000 Oct 07; 42(3):267-8. PubMed ID: 11105634
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis.
    Upchurch KS, Heller K, Bress NM.
    J Am Acad Dermatol; 1987 Aug 07; 17(2 Pt 2):355-9. PubMed ID: 3624579
    [Abstract] [Full Text] [Related]

  • 8. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE.
    Scand J Rheumatol; 2007 Aug 07; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract] [Full Text] [Related]

  • 9. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
    Sakaue S, Sumitomo S, Kubo K, Fujio K, Yamamoto K.
    Rheumatology (Oxford); 2014 Aug 07; 53(8):1529-30. PubMed ID: 24609062
    [No Abstract] [Full Text] [Related]

  • 10. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J, Usami J, Watanabe D.
    Am J Dermatopathol; 2018 Jan 07; 40(1):57-59. PubMed ID: 28719435
    [Abstract] [Full Text] [Related]

  • 11. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA, Werth VP, Schumacher HR.
    J Rheumatol; 2000 Aug 07; 27(8):2041-4. PubMed ID: 10955351
    [Abstract] [Full Text] [Related]

  • 12. Vasculitis occurring during leflunomide therapy.
    Holm EA, Balslev E, Jemec GB.
    Dermatology; 2001 Aug 07; 203(3):258-9. PubMed ID: 11701983
    [Abstract] [Full Text] [Related]

  • 13. Leflunomide for active rheumatoid arthritis.
    Bruyn GA, Griep EN, Korff KJ.
    Lancet; 1999 May 29; 353(9167):1883; author reply 1883-4. PubMed ID: 10359439
    [No Abstract] [Full Text] [Related]

  • 14. Rheumatoid nodules located in the penis of a methotrexate-treated patient with rheumatoid arthritis.
    Essig KM, Mayet WJ, Mottrie AM, Helmreich-Becker I, Meyer zum Büschenfelde KH.
    Z Rheumatol; 1994 May 29; 53(5):314-6. PubMed ID: 7810240
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K.
    Mod Rheumatol; 2010 Feb 29; 20(1):86-9. PubMed ID: 19812889
    [Abstract] [Full Text] [Related]

  • 16. Cutaneous vasculitis after intermediate dose of methotrexate (IDMTX).
    Fondevila Carlos G, Milone Gustavo A, Santiago P.
    Br J Haematol; 1989 Aug 29; 72(4):591-2. PubMed ID: 2775662
    [No Abstract] [Full Text] [Related]

  • 17. The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate.
    Kaye O, Beckers CC, Paquet P, Arrese JE, Piérard GE, Malaise MG.
    J Rheumatol; 1996 Feb 29; 23(2):253-7. PubMed ID: 8882028
    [Abstract] [Full Text] [Related]

  • 18. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.
    Jeurissen ME, Boerbooms AM, van de Putte LB.
    Clin Rheumatol; 1989 Sep 29; 8(3):417-9. PubMed ID: 2805620
    [No Abstract] [Full Text] [Related]

  • 19. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM, Val-Bernal JF, Pesquera LC, Fernández-Llanio NE, Esteban JM, Blanco R, Alonso-Bartolome P, Gonzalez-Vela C, Rodríguez-Valverde V.
    Scand J Rheumatol; 2006 Sep 29; 35(4):322-3. PubMed ID: 16882599
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ, Kim HO, Kim HY, Park YM.
    J Dermatol; 2009 May 29; 36(5):284-7. PubMed ID: 19382999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.